FATE THERAPEUTICS INC - 8-K Filing
Fate Therapeutics enters into $100 million at-the-market equity offering agreement with Leerink Partners and terminates prior Jefferies agreement. (Items: 1.01 Entry into a Material Definitive Agreement, 1.02 Termination of a Material Definitive Agreement, 9.01 Financial Statements and Exhibits)
Tickers: $FATE